Prostate Cancer Clinical Trial
Official title:
Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial
Randomized clinical study of two CAM therapies, 1) Reiki and 2) Relaxation Response Therapy
with Cognitive Restructuring counseling (RRT with CR), compared to an education-only control
arm in patients about to begin an eight-week course of external beam radiotherapy (EBRx) for
prostate cancer.
Generally, we would like to examine the feasibility of studying Reiki and RRT with CR in
patients with prostate cancer, and to obtain preliminary results on the effectiveness of
these treatments compared to controls.
Specific objectives:
1. Determine the proportion of eligible patients who agree to participate in the study
2. Measure compliance with CAM therapy interventions
3. Measure compliance with physiologic and psychological outcome measurement assessments
4. Assess differences between experimental and control groups on measures on depression,
anxiety, quality of life, salivary cortisol levels and an immunomarkers
Part of the mission of the Dana-Farber/Brigham and Women's Cancer Center is to enhance the
quality of life for cancer patients and their families. Treatments and therapies specifically
designed to address changes in the cognitive, emotional and spiritual realm experienced by
patients as they attempt to cope with cancer are now routinely offered in addition to
standard and experimental medical therapies and fall into the realm of complementary and
alternative medicine (CAM) and support. Our patients may participate in support groups; work
with a social worker, psychologist or psychiatrist privately; learn about diet in seminars or
meet with a dietician; participate in art or music therapy; or participate in the many
programs offered by the Leonard P. Zakim Center, which include Reiki therapy, acupuncture,
acupressure, massage and therapeutic touch. All of these services are provided with the hope
that the participants derive some benefit, however intangible. That cancer patients
experience significant short- and long-term psychological distress associated with their
cancer diagnosis and treatment is well documented.1-4 Most feel a strong sense of lost
self-control and experience disturbances in appetite, sleep, concentration, and stamina.5-9
Anxiety and depression appear to be almost ubiquitous with a cancer diagnosis, including
those men diagnosed with prostate cancer.8,10-12 This may explain the prevalence of prostate
cancer support groups, internet sites and self-help books. However, we have little precise
information on our own prostate cancer population with regards to the choices they make
regarding CAM and no information on how CAM therapies affect them.
There are some data on the use of CAM in other prostate cancer populations.13-16 In a study
of 1,099 men, the prostate cancer diagnosis prompted 23.5% of the sample to start using some
form of CAM for health, and 67% of the group reported having used some form of CAM for
prostate health before being diagnosed.17 The study included 14 herbal or dietary therapies
and 16 mind-body therapies. There were demographic differences between patients who opted for
CAM use and those who did not. Patients choosing CAM were more likely to be white versus not,
and more likely to be college-educated versus not. The latter variable was particularly
significant in this analysis. A second study of patients living in and around San Francisco
reported on 543 prostate cancer patients who completed a 30-minute telephone interview
regarding complementary and alternative medicines.14 Overall, 30% of the participants used at
least one type of complementary or alternative medicine. CAM users were younger than
non-users and likely to be college graduates. In this group, herbal remedies and mental
health approaches were the most commonly utilized, followed by dietary changes. Twelve
percent of the population used two or more CAM approaches.11
For our own study, we chose to look at two forms of CAM, Reiki and relaxation response
therapy (RRT). These two were chosen as we had some evidence of utilization within our own
cancer population. Reiki treatment is given at the Zakim Center. In the four years since the
Zakim Center opened, there have been approximately 300 patient visits for Reiki therapy.
Reiki is an energy healing method discovered in the late 1800s in Japan. The word Reiki is
made up of two Japanese words: Rei, an unlimited universal power of force that acts in all
created matter; and Ki, a living spirit energy that applies to the physical principle of
life. Licensed Reiki Masters perform Reiki. All of the Reiki Masters at the Zakim Center are
also registered nurses. Subjects often express an enhanced sense of well-being and relaxation
after a Reiki session, according to the Reiki practitioners, and most return for at least one
more session. Led by Susan DeCristofaro, the Reiki experience at the Zakim Center has been
standardized. Here, Reiki is given for acute and chronic pain, headache, depression, anxiety,
nausea, vomiting and insomnia. The fee for a Reiki session is $55.00. However, the effects of
receiving Reiki have not been subjected to rigorous scientific study. In a review of energy
healing, eleven studies looking at Reiki were reviewed. Of these, seven showed a beneficial
effect,18-22 three showed no effect21,23,24 and one had a negative effect.25 We believe,
after review of this data, that there are many unanswered questions about this treatment.
The second CAM of interest to us was relaxation response therapy (RRT), described and
pioneered at the Mind/Body Medical Institute, directed by Herbert Benson, MD. The Mind/Body
Medical Institute is an independent, nonprofit organization dedicated to the study of
mind/body interactions, including RRT. Three to four hundred cancer patients per year
participate in programs at the Mind/Body Medical Institute. Interventions using RRT in
combination with cognitive restructuring (CR) counseling are commonly employed and are felt
to be 'successful' in cancer patients by the practitioners who deliver them.
The term "relaxation response" was first coined in 1974.26,27 This technique has two
characteristics: repetition of a word or phrase and a disregard of everyday thoughts. The
elicitation of the RR down-regulates the sympathetic nervous system. It is characterized by
reductions in oxygen consumption, respiratory rate, blood pressure, heart rate and arterial
blood lactate. The mind/body state achieved with RR is consistent with a wakeful,
hypometabolic physiological state.28 EEG studies clearly differentiate the RR from sleep.29
PET30 and fMRI31 studies have correlated specific regional changes in brain activity with the
elicitation of the RR. When the patient is in a relaxed state, the therapist focuses on
helping him to identify emotions, negative thoughts or anxieties and assisting him to deal
with these thoughts in a more constructive way. This is called "cognitive restructuring" and
it is an integral part of RT.
RRT is believed to be a useful therapeutic intervention in numerous conditions including:
headache;32-34 premature ventricular contractions in stable ischemic heart disease or
hypertension;35-38 anxiety;39,40 stress symptoms;41 cardiac surgery;37 pain relief and
anxiety reduction in femoral arteriography;42 premenstrual syndrome;43 infertility;44
psychosomatic complaints;45 chronic pain;46-48 and insomnia.29 Other investigators have also
found that RRT techniques were effective in the treatment of rheumatoid arthritis. The fee
for RT with cognitive restructuring is $100.00 per hour, paid for privately or through
insurance.
Thus, we identified two reasonably mature CAM therapies offered and apparently utilized by
our own patients, paid for by the patients and their insurance providers, believed by the
practitioners to be beneficial to patients but without much solid evidence to support their
use. We also know that prostate cancer patients have a high level of interest in CAM. With
this in mind, we applied for and received a grant from the Advanced Medical Research
Foundation and submitted a protocol to the Dana-Farber/ Harvard Cancer Center Internal Review
Board with the primary aim of assessing the feasibility of recruiting and maintaining
enrollment in CAM therapy during an 8-week course of RT and a 2-month follow-up period. Our
protocol was accepted, #05-005, and is now accruing patients.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
| Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
| Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
| Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
| Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
| Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
| Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
| Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
| Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
| Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
| Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
| Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |